Possible selection effects for radiation risk estimates in Japanese A-bomb survivors: Reanalysis of acute radiation symptoms data

Radiation and Environmental Biophysics

Volumn 45, Issue 1, 2006, Pages 17-26

  Hunter, Nezahat ^a   Muirhead, Colin R ^a   Zhang, Wei ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

A-BOMB SURVIVORS; LEUKAEMIA; LIFE SPAN STUDY (LSS); POISSON REGRESSION; RADIATION SYMPTOMS DATA;

BOMBING; CARDIOVASCULAR SYSTEM; DATA ACQUISITION; DISEASES; ONCOLOGY; POISSON RATIO; REGRESSION ANALYSIS; RISK ASSESSMENT;

RADIATION EFFECTS;

ACUTE DISEASE; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATOMIC BOMB; ATOMIC BOMB SURVIVOR; BURN; CANCER PATIENT; CARDIOVASCULAR DISEASE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DATA COLLECTION METHOD; DEATH; FEMALE; HUMAN; INFANT; JAPAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; POISSON DISTRIBUTION; RADIATION CARCINOGENESIS; RADIATION HAZARD; RADIATION INJURY; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SOLID TUMOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOM;

ADULT; AGED; COHORT STUDIES; HUMANS; JAPAN; LEUKEMIA, RADIATION-INDUCED; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; POISSON DISTRIBUTION; RADIATION; RADIATION DOSAGE; RADIOACTIVE FALLOUT; RISK; SEX FACTORS; SURVIVORS;

EID: 33746750912     PISSN: 0301634X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00411-006-0040-9     Document Type: Article

References (23)

1. Pierce DA, Preston DL (2000) Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res 154:178-186
2. Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsui T, Nonaka H, Thompson DE, Soda M, Mabuchi K (1994) Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 137:S68-S97
3. Preston DL, Pierce DA, Shimizu Y, Cullings HM, Fujita S, Funamoto S, Kodama K (2004) Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat Res 162:377-389
4. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K (2003) Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and non-cancer disease mortality: 1950-1997. Radiat Res 160:381-407
5. Gilbert ES, Ohara JL (1984) An analysis of various aspects of atomic bomb dose estimation at RERF using data on acute radiation symptoms. Radiat Res 100:124-138
6. Neriishi K, Stram DO, Vaeth M, Mizuno S, Akiba S (199) The observed relationship between the occurrence of acute radiation effects and leukemia mortality among A-bomb survivors. Radiat Res 125:206-213
7. Stewart AM, Kneale GW (2000) A-bomb survivors: factors that may lead to a re-assessment of the radiation hazard. Int J Epidemiol 29:708-714
8. Little MP (2002) Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors. Int J Radiat Biol 78:1001-1010
9. Shimizu Y, Kato H, Schull WJ, Hoel DG (1992) Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86). Radiat Res 130:249-266
10. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S, Preston DL (1994) Cancer incidence in atomic bomb survivors, Part II: solid tumours, 1958-1998. Radiat Res 137:S17-S67
11. Preston DL, Lubin JA, Pierce DA, McConney ME (1993) Epicure user's guide
12. UNSCEAR (1994) United Nations Scientific Committee on the Effects of Atomic radiation. Sources and Effects of Ionising radiation. United Nations, New York
13. UNSCEAR (2000) United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionising Radiation. United Nations, New York
14. Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K (1996) Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat Res 146:1-27
15. Shimizu Y, Kato H, Schull WJ, Preston DL, Fujita S, Pierce DA (1989) Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses. Radiat Res 118:502-524
16. Stewart AM (1997) A-bomb data: detection of bias in the Life Span Study cohort. Environ Health Perspect 105:1519-1521
17. Stewart AM, Kneale GW (1999) A-bomb survivors: reassessment of the radiation hazard. Med Confl Surviv 15(1):47-56
18. Little MP (2001) Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors. Int J Radiat Biol 77:431-464
19. Little MP, Hawkins MM, Charles MW and Hilderth NG (1992) Fitting the Armitage_Doll model to radiation-exposed cohorts and implications for population risks. Radiat Res 132:207-221,
20. and Little MP, Hawkins MM, Charles MW and Hilderth NG Radiat Res 137:124-128
21. Little MP (1995) Are two mutations sufficient to cause cancer? Some generalisations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the multistage model of Armitage and Doll. Biometrics 51:1278-1291
22. Little MP and Muirhead CR (1997) Curvilinearity in the dose response curve for cancer in Japanese atomic bomb survivors. Environ Health Perspect 105(suppl 6):1505-1509
23. Pierce DA, Stram DO and Vaeth M (1990) Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res 123:275-284